Valliant John

Chief Executive Officer at Fusion Pharmaceuticals Inc.

Sold, on record
$1.6M
Dollars the filings state
Form 4 sales
16
Latest Apr 27, 2022
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Fusion Pharmaceuticals Inc.Plan not stated
    Mar 23, 2022 2022

    Sold 4,800 shares at $7.52 ($36k)

    Valliant John, Chief Executive Officer

    Sold 1.3% of holdings ($2.9M position)377,560 shares left0.3x usual sizeFiling

  2. 2 Form 4 sale Fusion Pharmaceuticals Inc.Plan not stated
    Mar 29, 2022 +6 days

    Sold 10,300 shares at $7.54 ($78k)

    Valliant John, Chief Executive Officer

    Sold 2.7% of holdings ($2.8M position)367,260 shares left0.7x usual sizeFiling

  3. 3 Form 4 sale Fusion Pharmaceuticals Inc.Plan not stated
    Mar 30, 2022 +1 day

    Sold 300 shares at $7.52 ($2k)

    Valliant John, Chief Executive Officer

    Sold 0.1% of holdings ($2.8M position)366,960 shares left0x usual sizeFiling

  4. 4 Form 4 sale Fusion Pharmaceuticals Inc.Plan not stated
    Apr 5, 2022 +6 days

    Sold 3,800 shares at $7.72 ($29k)

    Valliant John, Chief Executive Officer

    Sold 1% of holdings ($2.8M position)363,160 shares left0.4x usual sizeFiling

  5. 5 Form 4 sale Fusion Pharmaceuticals Inc.Plan not stated
    Apr 8, 2022 +3 days

    Sold 2,181 shares at $7.55 ($16k)

    Valliant John, Chief Executive Officer

    Sold 0.6% of holdings ($2.7M position)360,979 shares left0.3x usual sizeFiling

  6. 6 Form 4 sale Fusion Pharmaceuticals Inc.Unusual
    Apr 13, 2022 +5 days

    Sold 32,849 shares at $6.87 ($226k)

    Valliant John, Chief Executive Officer

    Sold 9.1% of holdings ($2.5M position)328,130 shares left6.8x usual sizeFiling

  7. 7 Form 4 sale Fusion Pharmaceuticals Inc.Plan not stated
    Apr 21, 2022 +8 days

    Sold 1,289 shares at $6.01 ($8k)

    Valliant John, Chief Executive Officer

    Sold 0.4% of holdings ($2M position)326,841 shares left0.2x usual sizeFiling

  8. 8 Form 4 sale Fusion Pharmaceuticals Inc.Plan not stated
    Apr 27, 2022 +6 days

    Sold 8,694 shares at $6.04 ($53k)

    Valliant John, Chief Executive Officer

    Sold 2.7% of holdings ($2M position)318,147 shares left1.8x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (16)

Form 144 notices and Form 4 sales by Valliant John
Source
Apr 27, 2022Apr 27, 2022Fusion Pharmaceuticals Inc.Chief Executive OfficerForm 4 sale8,694$53k2.7%Plan not statedSEC
Apr 21, 2022Apr 22, 2022Fusion Pharmaceuticals Inc.Chief Executive OfficerForm 4 sale1,289$8k0.4%Plan not statedSEC
Apr 13, 2022Apr 13, 2022Fusion Pharmaceuticals Inc.Chief Executive OfficerForm 4 sale32,849$226k9.1%UnusualSEC
Apr 8, 2022Apr 8, 2022Fusion Pharmaceuticals Inc.Chief Executive OfficerForm 4 sale2,181$16k0.6%Plan not statedSEC
Apr 5, 2022Apr 5, 2022Fusion Pharmaceuticals Inc.Chief Executive OfficerForm 4 sale3,800$29k1.0%Plan not statedSEC
Mar 30, 2022Apr 1, 2022Fusion Pharmaceuticals Inc.Chief Executive OfficerForm 4 sale300$2k0.1%Plan not statedSEC
Mar 29, 2022Mar 29, 2022Fusion Pharmaceuticals Inc.Chief Executive OfficerForm 4 sale10,300$78k2.7%Plan not statedSEC
Mar 23, 2022Mar 24, 2022Fusion Pharmaceuticals Inc.Chief Executive OfficerForm 4 sale4,800$36k1.3%Plan not statedSEC
Mar 21, 2022Mar 21, 2022Fusion Pharmaceuticals Inc.Chief Executive OfficerForm 4 sale3,604$27k0.9%Plan not statedSEC
Mar 16, 2022Mar 16, 2022Fusion Pharmaceuticals Inc.Chief Executive OfficerForm 4 sale1,500$10k0.4%Plan not statedSEC
Mar 11, 2022Mar 14, 2022Fusion Pharmaceuticals Inc.Chief Executive OfficerForm 4 sale2,822$20k0.7%Plan not statedSEC
Mar 8, 2022Mar 8, 2022Fusion Pharmaceuticals Inc.Chief Executive OfficerForm 4 sale14,504$104k3.6%Plan not statedSEC
Mar 3, 2022Mar 3, 2022Fusion Pharmaceuticals Inc.Chief Executive OfficerForm 4 sale27,593$205k6.4%Plan not statedSEC
Feb 28, 2022Feb 28, 2022Fusion Pharmaceuticals Inc.Chief Executive OfficerForm 4 sale13,752$103k3.1%Plan not statedSEC
Feb 23, 2022Feb 23, 2022Fusion Pharmaceuticals Inc.Chief Executive OfficerForm 4 sale38,297$298k7.9%Plan not statedSEC
Feb 17, 2022Feb 17, 2022Fusion Pharmaceuticals Inc.Chief Executive OfficerForm 4 sale47,502$384k8.9%Plan not statedSEC